Targeting the pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation

We show that the PDK/PDH axis is skewed in human AAA. Through the inhibition of PDK, in vitro and in vivo, we demonstrated that the PDK/PDH axis is a key regulator of vascular- and neutrophil-associated pathological responses with AAA formation. Our study pinpoints immunometabolic reprogramming using PDK inhibitors as an attractive strategy to fight AAA disease.

Authors

Institutions

Publication Details

Journal
Cardiovascular Research
Published
2025-03-04
DOI
https://doi.org/10.1093/cvr/cvaf032
Citations
6
Primary Topic
Macrophage Migration Inhibitory Factor
Type
article
Field-Weighted Citation Impact
4.78

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting the pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation

Mikkel G. Terp, Lars Melholt Rasmussen, Lasse Bach Steffensen, Daniel F.J. Ketelhuth et al.
6 citations
Cardiovascular Research
Macrophage Migration Inhibitory Factor
4.78
article

Targeting the pyruvate dehydrogenase kinase/pyruvate dehydrogenase axis modulates neutrophil and smooth muscle cell pathological responses and prevents abdominal aortic aneurysm formation

Mikkel G. Terp, Lars Melholt Rasmussen, Lasse Bach Steffensen, Daniel F.J. Ketelhuth, Emilie Grupe, Andrietta Grentzmann, María J. Forteza, Michelle Duen Nilsson, Jes S. Lindholt, Gustavo Luis Tripodi, Maja Dembić, Mark Burton, Maria Sabater‐Lleal, Silke Griepke, Gerard Temprano‐Sagrera, Pia Søe Jensen, Hans Christian Beck, Micaella Pereira da Fonseca, Jane Stubbe, Janne Fuglsang Hansen, Mads Thomassen, Yousef Tallouzi
article en
6 citations

Abstract

We show that the PDK/PDH axis is skewed in human AAA. Through the inhibition of PDK, in vitro and in vivo, we demonstrated that the PDK/PDH axis is a key regulator of vascular- and neutrophil-associated pathological responses with AAA formation. Our study pinpoints immunometabolic reprogramming using PDK inhibitors as an attractive strategy to fight AAA disease.

Cardiovascular ResearchVol. 121(8)
University of Southern Denmark (DK), Odense University Hospital (DK), Hospital de Sant Pau (ES), Karolinska Institutet (SE), Centre for Biomedical Network Research on Rare Diseases (ES), Centro de Investigación Biomédica en Red (ES), Region of Southern Denmark (DK), BioClinicum (Russia) (RU), Institut de Recerca Sant Pau (ES)
Hjerteforeningen, Fundació la Marató de TV3, European Commission, Novo Nordisk, Syddansk Universitet, Novo Nordisk Fonden, Simon Fougner Hartmanns Familiefond, HORIZON EUROPE Framework Programme, Instituto de Salud Carlos III, Agencia Estatal de Investigación, European Social Fund
Openalex Percentile: Top 5%
Macrophage Migration Inhibitory Factor
4.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.